menu
    • menu

    Company profile for EnPlusOne Biosciences

    NEW Drugs in Dev: 1
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EnPlusOne is dedicated to advancing RNA technology through its innovative ezRNA™ synthesis platform. This stepwise innovation enables the incorporation of diverse nucleotide modifications, offering a more sustainable and scalable approach to manufacturing therapeutic RNA at commercial levels. Beyond direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a wide range of RNA applications, delivering cutting-edge solution...
    EnPlusOne is dedicated to advancing RNA technology through its innovative ezRNA™ synthesis platform. This stepwise innovation enables the incorporation of diverse nucleotide modifications, offering a more sustainable and scalable approach to manufacturing therapeutic RNA at commercial levels. Beyond direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a wide range of RNA applications, delivering cutting-edge solutions for the growing RNA-based therapeutic field. We are on a mission to bring the power of RNA and its transformative potential to the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnPlusOne BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    313 Pleasant St, 4W, Watertown, Massachusetts 02472
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enplusonebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EnPlusOne Biosciences Welcomes Jim Weissman to Board
    EnPlusOne Biosciences Welcomes Jim Weissman to Board

    28 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528449583/en/EnPlusOne-Biosciences-Welcomes-Biotech-Veteran-Jim-Weissman-to-Board-of-Directors

    BUSINESSWIRE
    28 May 2026
    Share Share
    EnPlusOne Advances ezRNA Platform for Next-Gen RNA Therapeutics
    EnPlusOne Advances ezRNA Platform for Next-Gen RNA Therapeutics

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512154863/en/EnPlusOne-Biosciences-Highlights-Significant-Advancements-to-its-ezRNA-Enzymatic-RNA-Synthesis-Platform-and-Introduces-Novel-Modifications-for-Next-Generation-RNA-Therapeutics

    BUSINESSWIRE
    12 May 2026
    Share Share
    EnPlusOne Biosciences To Present New Data at TIDES USA
    EnPlusOne Biosciences To Present New Data at TIDES USA

    15 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250515266098/en/EnPlusOne-Biosciences-To-Present-New-Data-at-TIDES-USA

    BUSINESSWIRE
    15 May 2025
    Share Share
    EnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO
    EnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO

    17 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250417547229/en/EnPlusOne-Biosciences-Appoints-Clare-Murray-Ph.D.-as-CEO

    BUSINESSWIRE
    17 Apr 2025
    Share Share
    EnPlusOne Biosciences Raises $10M in Financing
    EnPlusOne Biosciences Raises $10M in Financing

    19 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250219227052/en

    BUSINESSWIRE
    19 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search